Bayer Aktiengesellschaft

Bayer Intellectual Property Gmbh

Bayer Schering Pharma Ag

Aicuris Gmbh + Co. Kg.

Bayer Healthcare Aktiengesellschaft

Bayer Cropscience Ag

Lanxess Deutschland Gmbh

Bayer Pharma Aktiengesellschaft

Aicuris Anti-Infective Cures Gmbh

Aic246 Ag & Co. Kg

Rolf Grosser

Walter Lange

Dieter Arlt

Bruno Bomer

Dieter Lang

Karl-Heinz Schlemmer

Michael Grosse-Bley

Peter Kolkhof

Kerstin Henninger

Mario Jeske

Holger Zimmermann

Guy Hewlett

Susanne Nikolic

Peter Nell

Tobias Wunberg

Judith Baumeister

Rudolf Schohe-Loop

Thomas Lampe

Ulrich Betz

Lars Bärfacker

Ingo Flamme

Klaus Münter

Santiago Figueroa Perez

Adam Nitsche

Karl-Erwin Piejko

Jörg Keldenich

Franz-Peter Hoever

Uwe Zweering

Alexander Kuhl

Andreas Knorr

Dietmar Bielefeldt

Heike Heckroth

Joerg Keldenich

Barbara Albrecht-Küpper

Frank Süβmeier

Elke Hartmann

Jens-Kerim Ergüden

Heike Gielen-Haertwig

Christian Laue

Tse-I Lin

Wolfram Sirges

Burkhard K&ouml;hler

Jürgen Reefschläger

Martina Klein

Christoph Erdelen

Stefan Dutzmann

Albrecht Marhold

Klaus Stenzel

Hans-Josef Buysch

Karl G Metzger

Andreas Turberg

Wolfgang Podszun

Manfred Jautelat

Uwe Petersen

Thomas Schenke

Rainer Endermann

Burkhard Kohler

Astrid Mauler-Machnik

Bernd Gallenkamp

Rainer Gross

Rolf Angerbauer

Timothy B Lowinger

Carsten Schmeck

Lothar Puppe

Matthias Schramm

Andreas Krebs

Alexander Hillisch

Martin Hendrix

Kai Thede

Gerhard Franckowiak

Hanns-Ingolf Paul

Andrew Plant

Gunter Thomas

Olaf Hansen

Gerald Kleymann

Herbert Diehl

Rudy Schreiber

Klaus Dieter Bremm

Toshiki Murata

Ulrich Niew&ouml;hner

Olaf Prien

Holger Paulsen

Takashi Yoshino

Kevin Bacon

Yuji Koriyama

Thomas Geller

Michael Gerisch

Thomas Krämer

Franz-Josef Van Der Staay

Kinji Fuchikami

Ursula Pentling

Elisabeth Woltering

Hiroki Sato

Frank Süssmeier

Armin Kern

Dagmar Schauss

Georg Schroder

Keiko Fukushima

Sachiko Sakakibara

Kai Rohlk

The invention relates to substituted dihydroquinazolines and to processes for their preparation and also to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular for use as antiviral agents, in particular against cytomegalo viruses.

Substituted dihydroquinazolines

The present application relates to novel substituted 4-aryl-1,4-dihydro-1,6-naphthyridine-3-carboxamides, a process for their preparation, their use for the treatment and/or prophylaxis of diseases, and their use for the manufacture of medicaments for the treatment and/or prophylaxis of diseases, especially cardiovascular disorders.

Substituted 4-aryl-1,4-dihydro-1,6-naphthyridine amides and their use

Substituted-4-aryl-1,4-dihydro-1,6-naphthyridinamides and use thereof

The present application relates to novel aryl-substituted 3-cyano-5-thiazolyl- and 3-cyano-5-thiadiazolyl-1,4-dihydropyridines, a process for their preparation, their use for the treatment and/or prophylaxis of diseases, and their use for the manufacture of medicaments for the treatment and/or prophylaxis of diseases, especially cardiovascular disorders.

3-cyano 5-thiazaheteroaryl-dihydropyridine and the use thereof for the treatment of cardiovascular diseases

The present application relates to novel substituted 4-aryl-1,4-dihydro-1,6-naphthyridines, a process for their preparation, their use for the treatment and/or prophylaxis of diseases, and their use for the manufacture of medicaments for the treatment and/or prophylaxis of diseases, especially cardiovascular disorders.

Substituted 4-aryl-1,4-dihydro-1,6-naphthyridines and use thereof

The present application relates to novel aryl- or heteroaryl-substitued pyrido[2,3-d] pyrimidines of formula (I), pharmaceuitical compositions of the same, and a process for their preparation. Formula(I) is: wherein Ar is an aryl or heteroaryl substituent, and R, R, R, Ar, D, and E are as defined in the specification. Compounds and compositions of the present invention can be used in the treatment and/or prophylaxis of various disorders in humans and animals, including aldosteronism, high blood pressure, chronic heart failure, the sequelae of a myocardial infarction, cirrhosis of the liver, renal failure, and stroke.

Aryl-or heteroaryl-substituted pyrido[2,3-d] pyrimidines and pharmaceutical compositions of the same

The invention relates to heterocyclyl-substituted dihydroquinazolines of formula (I), to processes for their preparation, to medicaments containing them, and to methods for the treatment and/or prophylaxis of diseases, in particular, for use as anti-viral agents, in particular, against cytomegaloviruses.

Heterocyclyl-substituted dihydroquinazolines and their use as antiviral agents

The invention relates to substituted dihydroquinazolines and to a method for the production thereof, the use thereof for treating and/or preventing diseases and for producing drugs for treating and/or preventing diseases, in particular for the use of the inventive dihydroquinazolines in the form of antiviral agents, in particular against cytomegaloviruses.

Substituted dihydroquinazolines II

A novel (&#x2212;)-enantiomer of 2-[2-(1-chloro-cyclopropyl)-3-(2-chloro-phenyl)-2-hydroxypropyl]-2,4-dihydro-[1,2,4]-triazole-3-thione of the formula a process for preparing this novel active compound and its use as microbicide in crop protection and in the protection of materials.

(&#x2212;)-enantiomer of the 2-[2-(1-chloro-cyclopropyl)-3-(2-chlorophenyl)-2-hydroxypropyl]-2,4-dihydro-[1,2,4]-triazole-3-thione

The present application relates to novel 7-sulfanylmethyl-, 7-sulfinylmethyl- and 7-sulfonylmethylindole derivatives, processes for the preparation thereof, the use thereof alone or in combinations for the treatment and/or prevention of diseases, and the use thereof for the manufacture of medicaments for the treatment and/or prevention of diseases, especially for the treatment and/or prevention of cardiovascular disorders.

Substituted 7-sulfanylmethyl-, 7-sulfinylmethyl- and 7-sulfonylmethylindoles and the use thereof

The present application relates to novel 4-chromenonyl-1,4-dihydropyridinecarbonitriles, processes for their preparation, pharmaceutical compositions containing them, and their use for the treatment and/or prophylaxis of diseases, especially cardiovascular disorders.

4-Chromenonyl-1,4-dihydropyridinecarbonitriles and the use thereof

The present application relates to novel 4-chromenonyl-1,4-dihydropyridines, process for their preparation, their use for the treatment and/or prophylaxis of diseases, and their use for the manufacture of medicaments for the treatment and/or prophylaxis of diseases, especially cardiovascular disorders.

4-Chromenonyl-1,4-dihydropyridines and their use

The invention relates to dihydroquinazolines and methods for the production thereof, the use thereof in the treatment and/or prophylaxis of diseases, in addition to the use thereof in the production of medicaments in the treatment and/or prophylaxis of diseases, especially for use as anti-viral agents, especially against cytomegalo viruses.

2-(3-phenyl-2-piperazinyl-3,4-dihydroquinazolin-4-yl)acetic acids as antiviral agents, especially against cytomegaloviruses

Growing community of inventors

Leverkusen, Germany

Rolf Grosser